Paolo Frigio Nichelli Selected Research

Transforming Growth Factor-beta Type I Receptor

10/2019

Novel pathogenic TGFBR1 and SMAD3 variants identified after cerebrovascular events in adult patients with Loeys-dietz syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Frigio Nichelli Research Topics

Disease

4	Multiple Sclerosis 01/2018 - 04/2013
3	Idiopathic Generalized Epilepsy 01/2015 - 02/2014
1	Aortic Dissection 10/2019
1	Loeys-Dietz Syndrome 10/2019
1	Cerebral Infarction 10/2019
1	Acute Coronary Syndrome 01/2018
1	Guillain-Barre Syndrome 01/2017
1	Cerebrotendinous Xanthomatosis 04/2016
1	Narcolepsy 08/2015
1	Cataplexy 08/2015
1	Inflammation (Inflammations) 06/2015
1	Migraine Disorders (Migraine) 04/2015
1	Rolandic Epilepsy (Centrotemporal Epilepsy) 01/2015
1	Epilepsy (Aura) 01/2015
1	Seizures (Absence Seizure) 01/2015
1	Myoclonus (Nocturnal Myoclonus) 09/2014
1	Generalized Epilepsy 09/2014
1	Anemia 07/2014
1	Obesity 06/2013
1	Cerebral Hemorrhage 06/2013

Drug/Important Bio-Agent (IBA)

4	Immunoglobulin E (IgE)IBA 01/2015 - 02/2014
3	Oligoclonal BandsIBA 01/2017 - 04/2013
1	Transforming Growth Factor-beta Type I ReceptorIBA 10/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2019
1	Alemtuzumab (Campath)FDA Link 01/2018
1	Immunoglobulin G (IgG)IBA 01/2017
1	LipidsIBA 04/2016
1	CholesterolIBA 04/2016
1	Cholestanetriol 26-Monooxygenase (Cholestanetriol 26 Monooxygenase)IBA 04/2016
1	OrexinsIBA 08/2015
1	Pharmaceutical PreparationsIBA 08/2015
1	Retinaldehyde (Retinal)IBA 04/2015
1	Natalizumab (Tysabri)FDA Link 07/2014
1	Biological ProductsIBA 06/2013
1	Sepharose (Agarose)IBA 04/2013

Therapy/Procedure

1	Thrombectomy 10/2019
1	Therapeutics 10/2019
1	VBM protocol 09/2014